Colon Cancer Home > Erbutux

Were you looking for information on Erbitux? Erbutux is a common misspelling of Erbitux.
Erbitux® (cetuximab) is licensed for the treatment of two different kinds of cancer. Specifically, it is used to treat:
This drug is given by injection into a vein once a week. The process will typically take one to two hours, and you will be monitored for an hour afterward to make sure you aren't having an adverse reaction to Erbitux.
(Click Erbitux for more information on this medicine, including how it works, factors that affect your dose, and what to do if you are pregnant or breastfeeding. You can also click any of the links in the box to the right for more information.)
Written by/reviewed by:
Last reviewed by: Kristi Monson, PharmD;
Last updated/reviewed:
List of references (click here):
Other Articles in This eMedTV Presentation

Topics & Medications


Related Channels

eMedTV Links
Copyright © 2006-2020 Clinaero, Inc.

eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind. Site users seeking medical advice about their specific situation should consult with their own physician. Click Terms of Use for more information.

This site complies with the HONcode standard for trustworthy health information:
verify here.